The Wuxi Integrative Hospital of Chinese Traditional and Western Medicine

Wuxi, China

The Wuxi Integrative Hospital of Chinese Traditional and Western Medicine

Wuxi, China
SEARCH FILTERS
Time filter
Source Type

Jie X.,The Wuxi Integrative Hospital of Chinese Traditional and Western Medicine | Hua L.,The Wuxi Integrative Hospital of Chinese Traditional and Western Medicine | Jiang W.,The Wuxi Integrative Hospital of Chinese Traditional and Western Medicine | Feng F.,The Wuxi Integrative Hospital of Chinese Traditional and Western Medicine | And 2 more authors.
Cell Biochemistry and Biophysics | Year: 2012

Establishment of a detection platform for glioblastoma-dendritic cell (DC) vaccine preparation and to determine the efficacy of the vaccine in a clinical trial. Autologous glioblastoma-DC vaccine was prepared from a glioblast specimen procured from surgical resection. The specimen was used to enrich the vaccine with peripherally blood-derived DCs after heat-shock induced, glioblastoma apoptosis. The control group received conventional treatment of surgery and radio-chemotherapy post-operation. The therapeutic group received a combination of glioblastoma-DC vaccine and conventional therapy. A comparison of the functional immune parameters, including tumor control, rate live time, Karnofsky scores, and complications occurring in each group were observed and recorded. The proportions of peripheral CD3 +, CD3 +CD4 +, CD4 +/CD8 +, and NK cells were significantly higher after DC vaccination than the control group (P < 0.05). Serum levels of IL-2, IL-12, and IFN-γwere significantly higher after DC vaccination than in the control group (P < 0.05). Nine months after vaccination, tumor control rate is significantly improved in the DC group compared with the control group (P < 0.05); survival rate was significantly higher in DC group than in control group (P < 0.05) and the time to relapse was significantly longer in DC group than that in control group (P < 0.05). Karnofsky scores were better in DC vaccination group 6 and 9 months post-treatment compared with the control group (P < 0.05). The combination of glioma DC vaccine and radiotherapy/chemotherapy post-operatively enhances the immune function of patients, increases the tumor control rate, prolongs the survival time and relapse duration, improves the quality of life, and therefore provides a more effective intervention of treating glioblastoma. © 2011 Springer Science+Business Media, LLC.

Loading The Wuxi Integrative Hospital of Chinese Traditional and Western Medicine collaborators
Loading The Wuxi Integrative Hospital of Chinese Traditional and Western Medicine collaborators